- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05052905
VR-based Remote Rehabilitation for Pediatric ABI
Virtual Reality Based Rehabilitation of Vestibular and Oculomotor Function for Pediatric ABI in a Home Setting
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel
- ALYN Hospital Pediatric and Adolescent Rehabilitation Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- They are ALYN patients undergoing physiotherapy for mild to severe ABI;
- They experience symptoms of vestibular function such as vertigo, postural instability, or impaired ocular motility;
- They are between the ages of 8 and 18;
- The time since injury/event is between 10 days and 1 year after the injury/event;
- They are able to maintain stable and dynamic positioning of the head;
- They able to walk with or without assistive equipment, or use a wheelchairs with no need for head support, defined by a LSS (level of sitting scale) score of 3 or greater (scale range: 1-8);
- Are able to understand basic instructions;
- Have sufficient visual acuity and visual field to identify and track mid-size objects on a screen.
Exclusion Criteria:
- Psychological, neurological or cognitive disorders which could impede participation, such as a history of epileptic seizures;
- Untreated benign paroxysmal positional vertigo (BPPV);
- Are in early post-operative stages (to avoid risk of bleeding or cerebrospinal fluid leak);
- Hearing impairment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study
Exercises
|
LibraVR is a standalone VR-based rehabilitation software for use in physiotherapy. It is designed to work with standard off-the-shelf hardware that is tested and approved for use in conjunction with the software. LibraVR system consists of the software (LibraVR Clinic) running on a PC (database of patients, creation of protocols, uploading protocols to mobile), and the LibraVR Mobile APP that runs on commercial mobile smartphones embedded in a lightweight cardboard or plastic VR viewer that the child wears as they would eyeglasses. The software displays a range of immersive VR exercises. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vestibular Oculomotor Motor Screening (VOMS)
Time Frame: 6 months
|
Symptoms scoring from 0 (none) to 10 (severe)
|
6 months
|
|
Pediatric Vestibular Symptom Questionnaire (PVSQ)
Time Frame: 6 months
|
Score ranging from 0 (never) to 33 (most of the time) with a 4-Likert scale
|
6 months
|
|
Convergence Insufficiency Symptom Survey (CISS)
Time Frame: 6 months
|
Score ranging from 0 (never) to 56 (Always) with a 5-Likert scale
|
6 months
|
|
Dizziness Handicap Inventory (DHI)
Time Frame: 6 months
|
Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale
|
6 months
|
|
Dizziness Handicap Inventory for patients caregivers (DHI-PC)
Time Frame: 6 months
|
Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale
|
6 months
|
|
Pediatric Quality of Life Inventory (PEDSQL)
Time Frame: 6 months
|
Score ranging from 0 (worst) to 100 (best) with a 5-Likert scale
|
6 months
|
|
Modified Clinical Test of Sensory Interaction in Balance (mCTSIB)
Time Frame: 6 months
|
Time score ranging from 0 (unable to complete) to 120 (completed successfully) in one of three 30-seconds trials and four conditions
|
6 months
|
|
Berg Balance Scale (Berg)
Time Frame: 6 months
|
Score ranging from 0 (lowest level of function) to 56 (highest level of function) with a 5-Likert scale
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Naomi Gefen, ALYN Hospital Pediatric and Adolescent Rehabilitation Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 041-21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.